Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Daftar Pustaka PDF

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

DAFTAR PUSTAKA

Aliyi, M. H., & Belayneh Kefale, O. (2015). Problems of using


Hydrochlorothiazide Diuretic in Adult Diabetic Patient in Diabetic Clinic of
Adama Hospital Medical College, East Shoa Zone, Oromia Regional State,
Ethiopia. Global Journal of Medical Research, 15(2).

Bastaki, A. (2005). Diabetes Mellitus and Its Treatment. International journal of


Diabetes and Metabolism, 13(3), 111.

Baxter, Karen. (2008). Stockley’s Drug Interaction (8th Edition). Great Britain:
Pharmaceutical Press.

Cryer, P. E., Davis, S. N., & Shamoon, H. (2003). Hypoglycemia in Diabetes.


Diabetes care, 26(6), 1902-1912.

Departemen Kesehatan, R. I. (2005). Pharmaceutical Care untuk Penyakit


Diabetes Mellitus. Direktorat Bina Farmasi Komunitas dan Klinik, Ditjen
Bina Kefarmasian dan Alat Kesehatan, Jakarta.

DiPiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., Posey, L.
M., Pharmacotherapy 3rd, A. (2008). Pathophysiologic Approach 7th
Edition. McGraw Hill Companies, South Carolina.

Djakani, H., Masinem, T., & Mewo, Y. M. (2013). Gambaran Kadar Gula Darah
Puasa Pada Laki-Laki Usia 40-59 Tahun. Jurnal e-Biomedik,1(1).

Drug Interaction Checker. (2016). Retrieved from www.drugs.com.

Duerden, M., Avery, T. & Payne, R. (2013). Polypharmacy and Medicines


Optimisation. London: The King’s Fund.

Durga, B., & Pharm, B. (2007). Pattern of Potential Drug-Drug Interactions in


Diabetic Out-Patients in A Tertiary Care Teaching Hospital in Nepal. Med J
Malaysia, 62(4), 295.

Edwina, D. A., Manaf, A. & Efrida. (2015). Pola Komplikasi Kronis Penderita
Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS. Dr. M.
Djamil Padang Januari 2011 - Desember 2012. Jurnal Kesehatan
Andalas.4(1).

Fatimah, R. N. (2015). Diabetes Melitus Tipe 2. Majority, 4(05).

Fradgley, S. (2003). Interaksi Obat. Dalam: Aslam, M., Tan, C. K., dan Prayitno,
A. Farmasi Klinis. Jakarta: PT Elex Media Komputindo.
Gitawati, R. (2008). Interaksi obat dan beberapa implikasinya. Media Penelitian
dan Pengembangan Kesehatan, Vol 18 (4).

Gonzalez-Gonzalez, J. G., Mireles-Zavala, L. G., Rodriguez-Gutierrez, R.,


Gomez-Almaguer, D., Lavalle-Gonzalez, F. J., Tamez-Perez, H. E., ... &
Villarreal-Perez, J. Z. (2013). Hyperglycemia related to high-dose
glucocorticoid use in noncritically ill patients. Diabetology & metabolic
syndrome, 5(1), 1.

Guariguata, L., Whiting, D., Weil, C., & Unwin, N. (2011). The International
Diabetes Federation Diabetes Atlas Methodology for Estimating Global and
National Prevalence of Diabetes in Adults. Diabetes research and clinical
practice, 94(3), 322-332.

Guyton, A.C. & Hall, J.E., (2006). Textbook of Medical physiology. 11th Edition.
New Delhi: Elsevier Inc.

Handayani, K. (2015). Analisis Potensi Interaksi Obat Diabetes Melitus Pada


Resep Obat Pasien Rawat Jalan Di RSAL Dr. Mintohardjo. Skripsi. UIN
Syarif Hidayatullah. Jakarta.

International Diabetes Federation. (2013). IDF Atlas Sixth Edition.

Ismail, M., Iqbal, Z., Khan, M. I., Javaid, A., Arsalan, H., Farhadullah, H., ... &
Khan, J. A. (2013). Frequency, Levels and Predictors of Potential Drug-
Drug Interactions in a Pediatrics Ward of a Teaching Hospital in
Pakistan. Tropical Journal of Pharmaceutical Research, 12(3), 401-406.

Nolte,. M. S., & Karam, N. H. (2010). Hormon Pankreas dan Obat Antidiabetes.
Dalam: Katzung B.G. Farmakologi Dasar dan Klinik. Edisi 6. Jakarta: EGC

KDIGO. (2013). Clinical Practice Guideline for the Evaluation and Management
of Chronic Kidney Disease. Kidney International Supplement. 3(1).

Kesehatan, D., & RI, K. K. (2013). Riset Kesehatan Dasar. Jakarta: Badan
Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik
Indonesia.

Kohei, Kaku. (2010). Pathophysiology of Type 2 Diabetes and Its Treatment


Policy. JMAJ, 53(1), 41-46.

King, K. D., Jones, J. D., & Warthen, J. (2005). Microvascular and Macrovascular
Complications of Diabetes Mellitus. American Journal of Pharmaceutical
Education, 69(1-5), FF1.

Kurniawan, I. (2010). Diabetes Melitus Tipe 2 pada Usia Lanjut. Majalah


Kedokteran Indonesia, 60(12), 576-84.
Martin, J. (2011). British National Formulary edisi 61. United Kingdom: RPS
Publishing.

McEvoy, G.K. (2011). AHFS Drug Information Essentials. Bethesda: American


Society of Health-System Pharmacists.

Murthy, E. K., Renar, I. P., & Metelko, Z. (2002). Diabetes and Pragnancy.
Diabetologia Croatica 31-3, 2002.

Nag, K. A., Umesh, M., & Churi, S. H. O. B. H. A. (2011). Assessment of Drug-


Drug Interactions in Hospitalised Patients in India. Asian J Pharm Clin
Res,4(Suppl 1), S62-5.

Ndraha, Suzanna. (2014). Diabetes Melitus Tipe 2 Dan Tatalaksana Terkini.


Medicinus, 27(2).

Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., & Unakalamba, C. B. (2013).


The Pathogenesis and Pathophysiology of Type 1 and Type 2 Diabetes
Mellitus. Academic Journals, 4(4), 46-57.

Perkumpulan Endokrinologi Indonesia. (2011). Konsensus Pengelolaan dan


Pencegahan Diabetes Melitus tipe 2 di Indonesia.

Piette, J. (2003). Effectiveness of Self-management Education. Dalam: Gan D,


Allgot B, King H, Lefèbvre P, Mbanya JC, Silink M, penyunting. Diabetes
Atlas. Edisi ke-2. Belgium: International Diabetes Federation.

Ramatillah, D. L., Rinayanti, A., & Priambodo, H. (2014). Penatalaksanaan


Penyakit Diabetes Mellitus Tipe 2 Pada Pasien Rawat Inap Di Rsud Koja
Jakarta Utara. Jurnal Prospek Farmasi Indonesia (JPFI), 1(1), 1-9.
Rehman, A., Setter, S. M., & Vue, M. H. (2011). Drug-induced glucose
alterations part 2: drug-induced hyperglycemia. Diabetes Spectrum, 24(4),
234-238.

Rojas, L. B. A., & Gomes, M. B. (2013). Metformin: an old but still the best
treatment for type 2 diabetes. Diabetology & metabolic syndrome, 5(1), 1.

Sari, P. S., Jufri, M. & Sari, D. P., (2008). Analisis Interaksi Obat Antidiabetik
Oral Pada Pasien Rawat Jalan Di Rumah Sakit X Depok. Jurnal Farmasi
Indonesia, 4(1).

Sankar, V., Saaed, Y., Joseph, R. M., Azizi, H., & Thomas, P. M. (2015). Serious
Drug-Drug Interactions in the Prescriptions of Diabetic Patients. Medical
Sciences, 3(4), 93-103.
Setiawati. (2007). Interaksi Obat. Dalam: Gunawan, S. G., Setiabudy, R.,
Nafrialdi, Elysabeth. Farmakologi dan Terapi Edisi 5. Jakarta: Fakultas
Kedokteran Universitas Indonesia.

Shenfield, G. M., (2001). Drug Interaction with Oral Hypoglycaemic Drugs.


Australian Prescriber, 24(4).

Sitompul, R. (2011). Kortikosteroid dalam Tata Laksana Uveitis: Mekanisme


Kerja, Aplikasi Klinis, dan Efek Samping. Journal of the Indonesian
Medical Association, 61(06).

Soumya, D. & Srilantha, B. (2011). Late Stage Complications of Diabetes and


Insulin Resistance. J Diabetes Metab 2:167.

Suherman, S. K. (2007). Insulin dan Antidiabetik Oral. Dalam: Gunawan, S. G.,


Setiabudy, R., Nafrialdi, Elysabeth. Farmakologi dan Terapi Edisi 5. Jakarta:
Fakultas Kedokteran Universitas Indonesia.

Sweetman, S.C. (2009). Martindale The Complete Drug Reference Thirty-sixth


Edition. USA: Pharmaceutical Press.

Tatro, D.S. (2003). A to Z Drug Facts. San Francisco: Facts and Comparisons.

Tatro, D. (2008). Drug Interaction Facts. St. Louis, Missouri: Facts and
Comparison.

Tjay, T. H. & Rahardja, K. (2002). Obat-Obat Penting. Jakarta: PT. Elex Media
Komputindo.

Tornio, A., Niemi, Mikko., Neuvonen, P. J. & Beckham, J. T. (2012). Drug


Interactions with Oral Antidiabetic Agents: Pharmacokinetic Mechanisms
and Clinical Implications. Trends in Pharmacological Sciences. June 2012,
33(6).

Triplitt, C. (2006). Drug Interactions of Medications Commonly Used in Diabetes.


Diabetes spectrum, 19(4), 202-211.

Vonbach, P., Dubied, A., Krähenbühl, S., & Beer, J. H. (2008). Prevalence of
drug–drug interactions at hospital entry and during hospital stay of patients
in internal medicine. European journal of internal medicine, 19(6), 413-420.

Vue, M. H., & Setter, S. M. (2011). Drug-induced glucose alterations part 1: drug-
induced hypoglycemia. Diabetes Spectrum, 24(3), 171-177.

You might also like